The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria

被引:0
|
作者
Hillmen, P.
Hill, A.
Muus, P.
Duhrsen, U.
Risitano, A. M.
Schubert, J.
Young, N. S.
Schrezenmeier, H.
Szer, J.
Brodsky, R. A.
Socie, G.
Rollins, S. A.
Rother, R. P.
Bell, L.
Luzzatto, L.
机构
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] Radboud Univ Med Ctr, Nijmegen, Netherlands
[3] Univ Hosp, Essen, Germany
[4] Med Federico Univ 2, Naples, Italy
[5] Univ Saarland, Sch Med, D-6650 Homburg, Germany
[6] NHLBI, NIH, Bethesda, MD 20892 USA
[7] Inst Klin Transfus & Immunogenet, Helmholtzstr, Germany
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[10] Hosp St Louis, INSERM, Paris, France
[11] Alex Pahrmaceut Inc, Cheshire, CT USA
[12] Ist Toscano Tumori, Florence, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
102
引用
收藏
页码:34 / 34
页数:1
相关论文
共 50 条
  • [31] Eculizumab treatment for paroxysmal nocturnal haemoglobinuria in a patient with recurrent simultaneous multivessel coronary stent thrombosis
    De Maria, Giovanni Luigi
    Sarwar, Rizwan
    Banning, Adrian P.
    OXFORD MEDICAL CASE REPORTS, 2015, (01): : 167 - 169
  • [32] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [33] Efficacy of eculizumab in paediatric patients with paroxysmal nocturnal haemoglobinuria in the International PNH Registry
    Urbano-Ispizua, A.
    Munir, T.
    Kulasekararaj, A. G.
    Bartels, M.
    Patriquin, C. J.
    Hoechsmann, B.
    Maschan, A. A.
    Wilson, A.
    Gustovic, P.
    Schrezenmeier, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 122 - 122
  • [34] Infections during eculizumab therapy in a Dutch population of patients with paroxysmal nocturnal haemoglobinuria
    Schaap, Charlotte C. M.
    Grotens, Ayla
    de Haan, Anton F. J.
    Blijlevens, Nicole M. A.
    Langemeijer, Saskia M. C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (10) : 1534 - 1536
  • [35] Portal vein thrombosis in paroxysmal nocturnal haemoglobinuria
    Tomizuka, H
    Hatake, K
    Kitagawa, S
    Yamashita, K
    Arai, H
    Miura, Y
    ACTA HAEMATOLOGICA, 1999, 101 (03) : 149 - 152
  • [36] The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab
    Kelly, Richard
    Arnold, Louise
    Richards, Stephen
    Hill, Anita
    Bomken, Charlotte
    Hanley, John
    Loughney, Andrew
    Beauchamp, Jon
    Khursigara, Gus
    Rother, Russell P.
    Chalmers, Elizabeth
    Fyfe, Andrew
    Fitzsimons, Edward
    Nakamura, Ryotaro
    Gaya, Anna
    Risitano, Antonio M.
    Schubert, Joerg
    Norfolk, Derek
    Simpson, Nigel
    Hillmen, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) : 446 - 450
  • [37] Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond
    Risitano, A.
    Marando, L.
    Hill, A.
    Ranaldi, D.
    Seneca, E.
    Serio, B.
    Ricci, P.
    Selleri, C.
    Gianfaldoni, G.
    Mannelli, F.
    Milano, F.
    Amendola, A.
    Boschetti, C.
    Di Bona, E.
    Bonfigli, S.
    Barbano, F.
    Rodeghiero, F.
    Zanella, A.
    Iori, A.
    Notaro, R.
    Rother, R.
    Kroon, H.
    Hillmen, P.
    Luzzatto, L.
    Rotoli, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S142 - S142
  • [38] Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
    Brodsky, Robert A.
    Young, Neal S.
    Antonioli, Elisabetta
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Schubert, Jorg
    Gaya, Anna
    Coyle, Luke
    De Castro, Carlos
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw P.
    Bessler, Monica
    Kroon, Henk-Andre
    Rother, Russell P.
    Hillmen, Peter
    BLOOD, 2008, 111 (04) : 1840 - 1847
  • [39] Eculizumab in paroxysmal nocturnal haemoglobinuria (PNH): a report of all 153 patients treated in the UK
    Hill, A.
    Kelly, R.
    Kulasekararaj, A.
    Gandhi, S.
    Mitchell, L.
    Elebute, M.
    Richards, S.
    Cullen, M.
    Arnold, L.
    Large, J.
    Wood, A.
    Downing, T.
    McKinley, C.
    Brooksbank, G.
    Cohen, D.
    Gregory, W.
    Marsh, J.
    Mufti, G.
    Hillmen, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 3 - 4
  • [40] Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    Nature Biotechnology, 2007, 25 : 1488 - 1488